Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I
I. Baric et al., Sensitivity and specificity of free and total glutaric acid and 3-hydroxyglutaric acid measurements by stable-isotope dilution assays for the diagnosis of glutaric aciduria type I, J INH MET D, 22(8), 1999, pp. 867-881
Glutaric aciduria type I (GA I) is a recessive disorder caused by a deficie
ncy of glutaryl-CoA dehydrogenase (GCDH). The biochemical hallmark of the d
isease is the accumulation of glutaric acid and, to a lesser degree, of 3-h
ydroxyglutaric acid and glutaconic acid in body fluids and tissues. A subst
antial number of patients show only slightly, intermittently elevated or ev
en normal urinary excretion of glutaric acid, which makes early diagnosis a
nd treatment to prevent the severe neurological sequelae difficult. Further
more, elevated urinary excretion of glutaric acid can also be found in a nu
mber of other disease states, mostly related to mitochondrial dysfunction.
Stable-isotope dilution assays were designed for both glutaric acid and 3-h
ydroxyglutaric acid and their diagnostic sensitivity and specificity were e
valuated. Control ranges of glutaric acid in urine were 1.1-9.7mmol/mol cre
atinine before and 4.1-32 after hydrolysis. The respective values of 3-hydr
oxyglutaric acid were 1.4-8.0 and 2.6-11.7mmol/mol creatinine. For other bo
dy fluids, control ranges in mu mol/L were: for glutaric acid 0.55-2.9 (pla
sma), 0.18-0.63 (cerebrospinal fluid) and 0.19-0.7 (amniotic fluid); and fo
r 3-hydroxyglutaric acid, 0.2-1.36 (plasma), < 0.2 (cerebrospinal fluid) an
d 0.22-0.41 (amniotic fluid).
Twenty-five patients with GCDH deficiency were studied. Low excretors (12 p
atients) were defined by a urinary glutaric acid below 100mmol/mol creatini
ne down into the normal range, while high excretors (13 patients) had gluta
ric acid excretions well above this value. With and without hydrolysis ther
e was an overlap of glutaric acid values between patients and controls. Dia
gnostic sensitivity and specificity of 100% could only be achieved by the q
uantitative determination of 3-hydroxyglutaric acid with the newly develope
d stable-isotope dilution assay, allowing an accurate diagnosis of all pati
ents, regardless of the amount of glutaric acid excreted in urine.